Modulatory function of NMDA glutamate receptor on MC<Subscript>3</Subscript>/MC<Subscript>4</Subscript> receptors agonist-induced hypophagia in neonatal meat-type chicken

Melanocortin 3 and 4 receptors (MC₃R and MC₄R) are known as the main receptors for melanocortin-induced hypophagia in mammalian and poultry. Also, central glutamatergic system has mediatory role on function of the melanocortin system in some brain areas. So, the aim of the current study was to determine the role of MC₃/MC₄ receptors agonist on food intake and its interaction with glutamatergic in 3-h food-deprived (FD₃) neonatal broilers. In experiment 1, chickens were intracerebroventricular (ICV) injected with control solution, MTII (MC₃/MC₄ receptors agonist; 2.45, 4.8 and 9.8 pmol). In experiment 2, control solution, SHU9119 (MC₃/MC₄ receptors antagonist; 0.5, 1 and 2 nmol) were ICV injected. In experiment 3, birds ICV injected with control solution, SHU9119 (0.5 nmol), MTII (9.8 pmol) and co-injection of the SHU9119 + MTII. Experiments 4–8 were similar to experiment 3, except birds injected with MK-801 (NMDA glutamate receptors antagonist, 15 nmol), CNQX (AMPA glutamate receptors antagonist; 390 nmol), AIDA (mGLUR₁ glutamate receptors antagonist; 2 nmol), LY341495 (mGLUR₂ glutamate receptors antagonist; 150 nmol) and UBP1112 (mGLUR₃ glutamate receptors antagonist; 2 nmol) instead of SHU9119. Then, cumulative food intake was recorded until 120 min after injection. According to the results, dose dependent hypophagia observed after ICV injection of the MTII (p < 0.05). ICV injection of SHU9119 significantly increased food intake in birds (p < 0.05). Co-injection of SHU9119 + MTII significantly inhibited MTII- induced hypophagia in neonatal chicks (p < 0.05). In addition, hypophagia- induced by MTII was significantly attenuated with co-injection of MTII + MK-801(p < 0.05). These results suggested MC₃ and MC₄ receptors have inhibitory role on food intake and this effect is probably mediated by NMDA glutamate receptors in neonatal chickens.     

Involvement of histaminergic and noradrenergic receptors in the oxytocin-induced food intake in neonatal meat-type chicks

Oxytocin neurons have a physiological role in food intake and energy balance. Several studies have shown that central histaminergic and adrenergic systems synapse on oxytocin neurons but there is no information for their interaction on food intake regulation in birds. The purpose of this study was to examine the effects of intracerebroventricular (ICV) injection of α-fluoromethylhistidine (α-FMH, histidine decarboxylase inhibitor), chlorpheniramine (histamine H1 receptors antagonist), famotidine (histamine H2 receptors antagonist), thioperamide (histamine H3 receptors antagonist), prazosin (α1 receptor antagonist), yohimbine (α2 receptor antagonist), metoprolol (β1 adrenergic receptor antagonist), ICI 118,551 (β2 adrenergic receptor antagonist) and SR59230R (β3 adrenergic receptor antagonist) on oxytocin-induced hypophagia in 3-h food-deprived (FD₃) neonatal broiler chicken. In Experiment 1, 3 h-fasted chicks were given an ICV injection of saline, α-FMH (250 nmol), oxytocin (10 μg) and co-injection of α-FMH + oxytocin. Experiments 2–9 were similar to experiment 1 except birds were injected with chlorpheniramine (300 nmol), famotidine (82 nmol), thioperamide (300 nmol), prazosin (10 nmol), yohimbine (13 nmol), metoprolol (24 nmol), ICI 118,551(5 nmol) and SR59230R (20 nmol) instead of α-FMH, respectively. After injection cumulative food intake was measured until 120 min post injection. According to the results, ICV injection of oxytocin significantly decreased food intake in broiler chickens (P < 0.001). ICV injection of α-FMH significantly attenuated hypophagic effect of oxytocin (P < 0.001). Also, co-injection of chlorpheniramine plus oxytocin significantly decreased the effect of oxytocin on food intake (P < 0.001). Co-administration of thioperamide and oxytocin significantly amplified hypophagic effect of oxytocin in chickens (P < 0.001). In addition, ICI 118,551 attenuated hypophagic effect of oxytocin (P < 0.001); while famotidine, prazosin, yohimbine, metoprolol and SR59230R had no effect on oxytocin- induced food intake in FD3 broiler chickens. These results suggest that the effect of oxytocin on food intake is probably mediated by histaminergic (via H1 and H3 receptors) and noradrenergic (via β2 receptors) systems in broiler chickens.     

Serotonin-induced hypophagia is mediated via α2 and β2 adrenergic receptors in neonatal layer-type chickens

1. Serotoninergic and adrenergic systems play crucial roles in feed intake regulation in avians but there is no report on possible interactions among them. So, in this study, 5 experiments were designed to evaluate the interaction of central serotonergic and adrenergic systems on food intake regulation in 3 h food deprived (FD₃) neonatal layer-type chickens.

2. In Experiment 1, chickens received intracerebroventricular (ICV) injection of control solution, serotonin (56.74 nmol), prazosin (α₁ receptor antagonist, 10 nmol) and co-injection of serotonin plus prazosin. In Experiment 2, control solution, serotonin (56.74 nmol), yohimbine (α₂ receptor antagonist, 13 nmol) and co-injection of serotonin plus yohimbine were used. In Experiment 3, the birds received control solution, serotonin (56.74 nmol), metoprolol (β₁ receptor antagonist, 24 nmol) and co-injection of serotonin plus metoprolol. In Experiment 4, injections were control solution, serotonin (56.74 nmol), ICI 118.551 (β₂ receptor antagonist, 5 nmol) and serotonin plus ICI 118.551. In Experiment 5, control solution, serotonin (56.74 nmol), SR59230R (β₃ receptor antagonist, 20 nmol) and co-administration of serotonin and SR59230R were injected. In all experiments the cumulative food intake was measured until 120 min post injection.

3. The results showed that ICV injection of serotonin alone decreased food intake in chickens. A combined injection of serotonin plus ICI 118.551 significantly attenuated serotonin-induced hypophagia. Also, co-administration of serotonin and yohimbine significantly amplified the hypophagic effect of serotonin. However, prazosin, metoprolol and SR59230R had no effect on serotonin-induced hypophagia in chickens.

4. These results suggest that serotonin-induced feeding behaviour is probably mediated via α₂ and β₂ adrenergic receptors in neonatal layer-type chicken.     

The role of glutamatergic and GABAergic systems on serotonin- induced feeding behavior in chicken

It has been reported that serotonin can modulate glutamate and GABA release in central nervous system (CNS). The present study was designed to examine the role of glutamatergic and GABAergic systems on serotonin- induced feeding behavior in chickens. In Experiment 1 intracerebroventricular (ICV) injection of MK- 801(NMDA receptor antagonist, 15 nmol) performed followed by serotonin (10 μg). In experiments 2, 3, 4, 5, 6 and 7 prior to serotonin injection, chickens received CNQX (AMPA/kainate receptor antagonist, 390 nmol), AIDA (mGluR1 antagonist, 2 nmol), LY341495 (mGluR2 antagonist, 150 nmol), UBP1112 (mGluR3 antagonist, 2 nmol), picrotoxin (GABA A receptor antagonist, 0.5 μg), CGP54626 (GABAB receptor antagonist, 20 ng) respectively. Cumulative food intake was determined at 3 h post injection. The results of this study showed that the hypophagic effect of serotonin was significantly attenuated by pretreatment with MK- 801 and CNQX (p?<?0.05) but AIDA, LY341495 and UBP1112 had no effect (p?>?0.05). Also, the inhibitory effect of serotonin on food intake was amplified by picrotoxin (p?<?0.05) while CGP54626 had no effect (p?>?0.05). These results suggest that serotonin as a modulator probably interacts with glutamatergic (via NMDA and AMPA/Kainate receptors) and GABAergic (via GABAA receptor) systems on feeding behavior in chicken.     

Central histaminergic system interplay with suppressive effects of immune challenge on food intake in chicken

1. The aim of the current study was to investigate the interaction of the lipopolysaccharide (LPS) and histaminergic systems on appetite regulation in broilers. Effects of intracerebroventricular (ICV) injection of α-fluoromethylhistidine (α-FMH, histidine decarboxylase inhibitor), chlorpheniramine (histamine H₁ receptor antagonist), famotidine (histamine H₂ receptor antagonist) and thioperamide (histamine H₃ receptor antagonist) on LPS-induced hypophagia in broilers were studied.

2. A total of 128 broilers were randomly allocated into 4 experiments (4 groups and 8 replications in each experiment). A cannula was surgically implanted into the lateral ventricle. In Experiment 1, broilers were ICV injected with LPS (20 ng) prior to α-FMH (250 nmol). In Experiment 2, chickens were ICV injected with LPS followed by chlorpheniramine (300 nmol). In Experiment 3, broilers were ICV injected with famotidine (82 nmol) after LPS (20 ng). In Experiment 4, ICV injection of LPS was followed by thioperamide (300 nmol). Then, cumulative food intake was recorded until 4 h post-injection.

3. According to the results, LPS significantly decreased food intake. Chlorpheniramine significantly amplified food intake, and LPS-induced hypophagia was lessened by injection of chlorpheniramine. α-FMH, famotidine and thioperamide had no effect on LPS-induced hypophagia.

4. These results suggest that there is an interaction between central LPS and the histaminergic system where LPS-induced hypophagia is mediated by H₁ histamine receptors in 3 h food-deprived broilers.

     

Evaluation of xylanase and a fermentable xylo-oligosaccharide on performance and ileal digestibility of broiler chickens fed energy and amino acid deficient diets

The objective of this study was to evaluate the effect of a product consisting of a combination of xylanase and xylo-oligosaccharide (STBIO) on performance and ileal digestibility of broiler chickens fed energy and amino acid (AA) deficient diets. Day-old male Ross 308 broiler chicks were randomly allocated to 8 pens per treatment, with 25 chicks per pen. Treatments based on wheat-corn-soybean meal diets were arranged in a 3 × 2 factorial design: a positive control that met or exceeded nutrient recommendations (PC), a negative control diet with a 50 kcal/kg apparent metabolizable energy (AME) reduction (NC1) and NC1 with a 3% reduction in AA content (NC2), each with or without supplementation of 100 g/t of the STBIO. Body weight gain (BWG), feed intake, feed conversion ratio corrected for mortality (FCR) and the European production efficiency factor (EPEF) were recorded from 0 to 42 d. On d 42, ileal samples were collected to determine dry matter (DM), organic matter (OM), ash, protein and energy digestibility. A significant interaction was observed for BWG and feed intake (P < 0.001). The energy and AA reduction reduced (P < 0.05) BWG when compared to the PC. The effect of STBIO on BWG was greater in NC1 (+451 g/bird) than in NC2 (+314 g/bird) or PC (+176 g/bird) diets (P < 0.05), and that in NC2 with STBIO was equal to that in PC without STBIO, and that in NC1 with STBIO was equal to that in PC with STBIO. No interactions were observed on the EPEF or FCR; however, STBIO improved EPEF (P < 0.001) and FCR (P < 0.001) irrespective of the energy reduction or AA density. The intake of digestible DM, OM, ash and energy for the finisher period was increased with STBIO supplementation (P < 0.01). A significant interaction was observed for the intake of digestible protein. NC1 and NC2 reduced the intake of digestible protein; however, when STBIO was supplemented, it was improved in both diets to similar levels to the PC. The stimbiotic supplementation improved performance of broiler chickens fed all diets, particularly those deficient in AME and AA.     

Response of young broiler chickens to chronic injection of recombinant-derived human insulin-like growth factor-I

The purpose of this study was to determine if exogenous insulin-like growth factor-I (IGF-I) would improve growth rate or body composition of young broiler chickens. Broiler cockerels were given a daily intramuscular (im) injection of sodium acetate buffer (buffer control), 100 or 200 μg recombinant-derived human IGF-I (rhIGF-I) per kg body weight from 11 to 24 days of age. Exogenous IGF-I did not affect the average daily gain, average daily feed consumption, or the gain-to-feed ratio of broiler chickens. Although daily injection of 200 μg/kg of rhIGF-I reduced (P<0.05) body ash content, there was no significant effect of IGF-I treatment on either body fat or protein content. Plasma GH levels were depressed (P<0.05) by chronic treatment with rhIGF-I. In contrast, plasma levels of T₃ and T₄ were not affected by rhIGF-I treatment. The half-life of rhIGF-I in plasma was determined at 25 days of age in naive control or chronically-injected chickens after a single intravenous dose of 50 μg rhIGF-I/kg. We found a single compartment, first-order disappearance pattern of rhIGF-I from chicken plasma. The half-life (t_1/2) of rhIGF-I in plasma was similar (t_1/2 = 32.5 min) for naive controls (injected once) or chronically-treated chickens which had received a daily injection of rhIGF-I (100 or 200 μg/kg) for 14 d. These data indicate that daily injection of IGF-I cannot be used to enhance growth performance or body composition of broiler chickens when given during the early growth period. The depression of plasma GH levels in rhIGF-I-injected chickens supports a negative-feedback role of IGF-I on pituitary GH secretion.     

Endocannabinoid and nitric oxide interaction mediates food intake in neonatal chicken

1. The aim of the current study was to investigate the interaction of the nitric oxide and cannabinoidergic systems on feeding behaviour in neonatal chicken.

2. A total of 6 experiments were designed to evaluate the interaction between cannabinoidergic and nitrergic systems on food intake in 3-h food-deprived (FD₃) neonatal chickens. In Experiment 1, chickens received intracerebroventricular (ICV) injections of saline, 2-arachidonoylglycerol (2-AG) (a CB₁ receptor agonist, 2 µg), l-arginine (nitric oxide precursor, 200 nmol) and co-administration of 2-AG + l-arginine. In Experiment 2, ICV injection of saline, 2-AG (2 µg), l-NAME (a nitric oxide synthesis inhibitor, 100 nmol) and their combination (2-AG + l-NAME) were applied to the birds. In Experiment 3, injections were saline, CB65 (a CB₂ receptor agonist, 1.25 µg), l-arginine (200 nmol) and CB65 + l-arginine. In Experiment 4, birds received ICV injection of saline, CB65 (1.25 µg), l-NAME (100 nmol) and CB65 + l-NAME. In Experiment 5, chickens were ICV injected with saline, l-arginine (800 nmol), SR141716A (a selective CB₁ receptor antagonist, 6.25 µg) and l-arginine + SR141716A. In Experiment 6, birds were injected with saline, l-arginine (800 nmol), AM630 (a selective CB₂ receptor antagonist, 5 µg) and l-arginine + AM630. Cumulative food intake was recorded until 2-h post injection.

3. ICV injection of CB₁ and CB₂ receptor agonists increased food intake. Co-injection of 2-AG + l-NAME increased the hyperphagic effects of CB₁ receptors. CB₂ receptor-induced food intake was not affected by co-administration of CB65 + l-NAME. l-Arginine decreased food intake and this effect was amplified by co-injection of l-arginine + SR141716A. However; CB₂ receptor antagonists had no effect on l-arginine-induced hypophagia.

4. The results suggest that there is an interaction between endogenous nitric oxide and the cannabinoidergic system on feeding behaviour which is mediated via CB₁ receptors in the neonatal chicken.

     

Intracerebroventricular injection of ghrelin produces hypophagia through central serotonergic mechanisms in chicken

It has been stated that central injection of ghrelin is acting as an anorexigenic peptide in chicken. Ghrelin activity was studied through some neuronal pathways. The present study was designed in 4 experiments to examine the hypophagic response of ghrelin through the central serotonergic system in chicken. The guide cannula was surgically implanted in the right lateral ventricle of the chickens. In experiment 1, intacerebroventricular injection with PCPA (1.5 mg) performed followed by ghrelin (0.6 nmol). In experiments 2, 3 and 4 prior to ghrelin injection, chickens received fluoxetine (10 μg), 8-OH-DPAT (15.25 nmol), SB242084 (1.5 μg) respectively via guide cannula intacerebroventricularly. Cumulative food intake was determined at 3 h post injection. The results of this study showed that flouxetine pretreatment significantly amplified ghrelin hypophagia in chicken (p?<?0.05). The hypophagic effect of ghrelin was attenuated by pretreatment with PCPA and SB242084 (p?<?0.05) but 8-OH-DPAT had no effect. These results suggest that hypophagic effect of ghrelin probably is mediated by serotonergic mechanisms via 5-HT_2C receptor.     

Influence of Dietary Metformin on the Growth Performance and Plasma Concentrations of Amino Acids and Advanced Glycation End Products in Two Types of Chickens

Glycation is a non-enzymatic reaction inducing the bonding of glucose to amino acids and proteins. Glycated amino acids are not useful for protein synthesis, suggesting that glycation reduces the utilization of amino acids. Metformin (MF) is well known as a therapeutic drug for type II diabetes that inhibits glycation. It is possible that treatment with MF raises the utilization of amino acids by the inhibition of glycation, thereby improving the growth performance of chickens. In the present study, therefore, we investigated the influence of dietary MF on the growth performance, and plasma concentrations of free amino acids and N^ε-(Carboxymethyl)lysine (CML), which is an advanced glycation end product, in layer (Experiment 1) and broiler (Experiment 2) chickens. From 7 d of age, chicks were allowed free access to one of the experimental diets containing MF at 3 supplementation levels (0, 150, and 300 mg/kg diet) for 14 days. Body weight and feed intake were measured every week. At the end of the experiments, blood and breast muscle (M. pectoralis major) were collected for further analysis. Dietary MF did not affect weight gain, feed intake, or feed efficiency in both layer and broiler chickens. Dietary MF at the level of 150 mg/kg diet increased breast muscle weight in both layer and broiler chickens. Dietary MF increased plasma concentrations of branched chain amino acids and decreased concentrations of CML in layer chickens, although it did not affect plasma concentrations of glucose. The present study suggested that dietary MF might have the potency to increase breast muscle weight of layer chickens with an increment in plasma concentrations of branched-chain amino acids.     

Effect of fasting and refeeding on blood glutathione and lipid peroxide concentration of cockerels and pullets

Changes of reduced glutathione (GSH) and TBARS (thiobarbituric acid-reactive products of lipid peroxidation) concentrations and activity of gamma-glutamyltransferase (GGT, EC 2.3.2.2) in the blood of Lohman brown cockerels and pullets in response to 48 hour food deprivation and 24 hour refeeding were examined. The experiment was performed on 61-day-old chickens. Blood samples ware collected from the wing vein (v. brachialis) in heparinized tubes for three times: control sampling before fasting, then after 48 hour food deprivation and after refeeding for 24 hours. Blood GSH concentration after refeeding in cockerels was significantly higher compared with prefasting and fasting values. The concentration of GSH in female chickens was significantly lower after fasting as well as after refeeding compared with control values. In addition to that, in pullets GSH concentration in refeeding was higher than in fasting conditions. The level of TBARS in blood in female and male chickens after fasting and refeeding were significantly lower than the prefasting values. The GGT activity on cockerels after 48 hour food deprivation was significantly higher compared with control sampling and in chickens refeed for 24 hours, whereas in pullets significant difference was exhibit compared only with control values. Concentration of GSH in control sampling in cockerels compared with those in pullets was significantly lower. After 48 hours of fasting, the level of GSH was significantly higher in the cockerels than in the pullets. Results of TBARS concentration in the pullets were higher of control and fasting values than in the cockerels. The GGT activity of control sampling was significantly higher in male chicken. Lipid peroxidation in chickens of both sexes decreased with fasting, but prooxidative-antioxidative processes were more intensive in female chickens, probably because they were not reach sexual maturity.     

Food deprivation and feeding of broiler chickens is associated with rapid and interdependent changes in the somatotrophic and thyrotrophic axes

1. In several experiments, hormonal changes in the somatotrophic axis, growth hormone (GH) sensitivity to a GH-secretagogue, thyroid hormones and their metabolising enzymes and plasma glucose levels were measured in relation to food deprivation and reinitiation after a single daily meal in 4- to 5-week-old male broiler chickens. 2. Floor-reared male broiler chickens were fed ad libitum or were restricted to a daily food intake of 40 or 45 g per d from the age of 2 weeks onwards. The daily food allowance was consumed in 0.5 h. 3. Food deprivation increased plasma GH concentrations but decreased GH-dependent variables such as plasma insulin-like growth factor-I and 3,3',5-triiodothyronine (T3) concentrations. Hepatic inner ring deiodinating type III activity was markedly elevated, presumably as a consequence of low hepatic GH receptor numbers, and is thought to be the causal mechanism for the low plasma T3 concentrations. Food intake reversed these variables in a time-related manner. 4. GH pulsatility characteristics, as calculated by deconvolution analysis, revealed profound changes between food restricted and ad libitum fed animals. Chickens deprived of food for about 23.5 h were characterised by an enhanced pulsatile GH release as reflected in the higher GH secretory burst amplitude, GH mass per burst, GH production rate and GH pulse frequency. These variables returned very quickly to normal values after refeeding. 5. In summary these experiments taken together demonstrate very clearly the interdependent and time-related changes of the somatotrophic and thyroid axes upon a single meal in previously food-deprived broiler chickens.     

Effects of dietary chitosan on fat deposition and lipase activity in digesta in broiler chickens

1. The effect of dietary chitosan on fat deposition and lipase activity in the small intestinal contents was investigated in broiler chickens fed an adequate or high metabolisable energy (ME) diet. 2. Male broiler chickens at 14 d old were fed on the adequate or high ME diet supplemented with 0 or 50 g/kg chitosan, which has a low viscosity, for 3 weeks. 3. Dietary chitosan did not affect food intake, body weight gain or food efficiency in either dietary ME groups. 4. Dietary chitosan reduced the excessive abdominal fat deposition induced by the high ME diet. 5. Dietary chitosan increased the weight of intestinal contents irrespective of dietary ME concentration. 6. Dietary chitosan decreased the lipase activity per g of small intestinal contents. 7. These results suggest that dietary chitosan with low viscosity decreases lipase activity and fat absorption in the small intestine, consequently resulting in a reduction of fat deposition in broiler chickens. 8. It was concluded that dietary chitosan with low viscosity can decrease body fat deposition without reducing food intake and body weight gain in broiler chickens.     

Hypophagic and dipsogenic effect of the 5‐HT1A receptor agonist 8‐OH‐DPAT in broiler chickens

The effects of the 5‐HT_1A receptor agonist 8‐OH‐DPAT on food and water intake in male broiler chickens were investigated. The injection of 25 or 50 μg/kg of 8‐OH‐DPAT 15 min before refeeding in fasted animals produced a decrease in food intake. No effect was observed in drinking. The injection of 25 or 50 μg/kg of the 8‐OH‐DPAT 60 min after the start of refeeding did not produce any significant modification in food intake. No effect on drinking was recorded. The agonist 8‐OH‐DPAT injected 15 min before water presentation in water‐deprived chickens, produced an increased drinking 60 min after the presentation of water. No effect on food intake was observed. The results show that the effect on food intake of the agonist 8‐OH‐DPAT in fasted–refed broiler chickens was similar to those observed in mammals and layer‐strain chickens. However, the agonist did not alter significantly the food intake when the broilers were fed 60 min before the injection. These results are contrary to the observed effects in mammals and in layer‐strain chickens. Probably, the selection for rapid growth rate in broilers causes modifications in the feeding control pattern. The comparison between broilers and layers strain may be a useful tool to elucidate the complex mechanisms involved in food and water intake regulation in chickens.     

Starch digestion rates in multiple samples of commonly used feed grains in diets for broiler chickens

In this study the starch digestion rates in broiler chickens from 18 samples of 5 commonly used feed grains (sorghum, wheat, maize, barley, triticale) were determined. The methodology to determine starch digestion rates in poultry is detailed herein. Starch digestion rates were not significantly different (P = 0.128) across the 18 feed grains, which reflects the wide variations that were observed within a given feedstuff. Nevertheless, starch digestion rates in broiler chickens offered wheat-based diets were significantly more rapid by 56.0% (0.117 versus 0.075 min⁻¹; P = 0.012) than their sorghum-based counterparts on the basis of a pair-wise comparison. In descending order, the following starch digestion rates were observed: wheat (0.117 min⁻¹), barley (0.104 min⁻¹), triticale (0.093 min⁻¹), maize (0.086 min⁻¹), sorghum (0.075 min⁻¹). The implications of these findings are discussed as they almost certainly have implications for poultry nutrition and the development of reduced crude protein diets for broiler chickens.     

Sodium salicylate attenuates lipopolysaccharide (LPS)-induced adipsia, but not hypophagia, in broiler chickens

A study was conducted to determine the influence of sodium salicylate on the behaviour and the food and water consumption of broiler chickens after lipopolysaccharide (LPS) injection. An oral dose of 100 mg/kg sodium salicylate was given and an acute phase reaction in broiler chickens was provoked through the intravenous injection of Escherichia coli LPS. Water intake was higher in the LPS and salicylate-treated group than in the positive control group. The salicylate treatment, however, did not restore the food intake, or influence the behaviour of the chickens. These data show that sodium salicylate has a positive effect on the water intake after intravenous injection of LPS in chickens and suggests that there is a difference in mechanism of action of food and water consumption after LPS injection in chickens.     

Stimulation of food intake and growth of chickens by cyproheptadine: lack of interaction with the effects of pinealectomy and melatonin

Cyproheptadine stimulates food intake and growth in some species of mammal; its effects are reported here in chickens. Growing cockerels of an egg-laying strain were given 0.32 mg/d by mouth, which resulted in significant increases in weight gain and food intake, including feeding during the night. Increasing daily doses of up to 1.6 mg/kg body weight stimulated intake in a dose-related manner, while 1.92 mg/kg had the same effect as 0.96 mg/kg. Neither pinealectomy, which is known to stimulate food intake, nor treatment with melatonin, which depresses intake, interacted with the effects of cyproheptadine on food intake, showing that its effect is not mediated by the pineal gland.     

Relative humidity at moderate ambient temperatures: its effect on male broiler chickens and turkeys

1. The effect of relative humidity (RH, 40% to 75%) at moderate ambient temperatures (Ta, 28 degrees and 30 degrees C) on the performance and thermoregulation of male broiler chickens and turkeys was studied at the age of 4 to 8 weeks. 2. Weight gain and food intake of male broiler chickens were significantly higher at 60% to 65% RH but food conversion efficiency was not affected by RH. In male turkeys, no effect of RH on performance was recorded. 3. Both chickens and turkeys controlled body temperature at normothermic levels during exposure to the experimental environmental conditions. 4. The rate of panting estimated from blood pH and pCO2 was lower in chickens exposed to 28 degrees C than to 30 degrees C. In turkeys, the rate was lower than that recorded in chickens at both Ta(s). 5. Plasma T3 was positively and significantly correlated with food intake. 6. It may be concluded that RH plays a role in the performance of chickens exposed to 30 degrees and 28 degrees C. whereas male turkeys must respond to RH at Ta >30 degrees C.     

霉变饲料中添加复方霉菌毒素吸附剂对肉鸡人工感染发生的影响

本试验旨在研究霉变饲料和／或添加复方霉菌毒素吸附剂对肉鸡人工感染发生的影响。选取140羽1日龄健康的AA肉鸡随机分成7个组．每组4个重复。第1组为空白对照组,饲喂基础日粮;第2组饲喂霉变饲料;第3～7组以混合感染病鸡病变组织匀浆饮水制作人工感染疾病模型;第3～7组分别饲喂基础日粮、霉变饲料、霉变饲料＋复方霉菌毒素吸附剂、霉变饲料＋复方霉菌毒素吸附剂＋抗氧化剂、霉变饲料＋复方霉菌毒素吸附剂＋抗氧化剂＋中药增免剂。试验期35d。结果发现,肉鸡摄入霉变饲料与摄入正常饲料相比,提高肉鸡料重比和死淘率,显著降低肉鸡增重、胸腺指数、法氏囊指数,显著降低血清IBDV、H9N1v和NDV抗体水平（P〈0．05）。给人工感染肉鸡饲喂霉变饲料与饲喂正常饲料相比．显著提高料重比和死淘率,显著降低肉鸡增重、胸腺指数和脾脏指数,显著降低血清IFN-1、IL-2、IL-4和IL-12含量以及LTR,显著降低血清IBDV、H9N1V和NDV抗体水平（P〈0．05）。霉变饲料中添加复方霉菌毒素吸附剂能显著提高混合感染肉鸡增重,并降低料重比和死淘率（P〈0．05）,显著提高胸腺指数、法氏囊指数（P〈0．05）,显著提高血清IBDV、H9N1V和NDV抗体水平（P〈0．05）。可见,霉变饲料可导致肉鸡免疫功能抑制,加重肉鸡混合感染病情;复方霉菌毒素吸附剂能有效缓解霉变饲料对人工感染肉鸡生产性能、免疫功能和病情的不利影响,抗氧化剂和免疫功能增强剂可减轻霉变饲料的毒性作用。     

Effect of sodium bentonite on the performance and blood variables of broiler chickens intoxicated with aflatoxins.

1. This study was conducted to evaluate the protective effect of natural sodium bentonite (NaB) in the prevention of toxic effects of aflatoxins. Five hundred and twenty-eight 1-d-old Ross male broiler chickens were housed in pens (22 chickens per pen) for 42 d. There were 3 inclusion rates of NaB (0, 2.5, and 5 g/kg) and 2 of aflatoxins (0 and 3 mg/kg food). Each treatment had 4 replicates of 22 chickens. 2. All chickens treated with aflatoxin and without bentonite were adversely affected. NaB treatment at 5.0 g/kg improved body weights at 42 d of age by 31.3%, increased food intake by 23.8% and improved productive efficiency by 40.1%. Weights of liver, heart, pancreas and crop and biochemical variables were not affected by dietary NaB. However, serum phosphorous concentration was reduced by 30% compared with chickens that received aflatoxin. 3. NaB caused no adverse effects on chickens that did not receive aflatoxin. 4. It is concluded that NaB at pH 7.9 partially neutralises the effects of aflatoxins on broiler chickens when included at 5.0 g/kg in the diet.